Top Biotechnology & Medical Research stocks in Europe
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LONNLonza AG | CH₣35.24bn | 33.93 | 0.82% |
ARGXargenx SE | €20.25bn | n/a | n/a |
GMABGenmab A/S | DKK126.19bn | 23.39 | n/a |
BANBBACHEM HOLDING AG | CH₣6.17bn | 54.76 | 0.97% |
ZEALZealand Pharma A/S | DKK39.82bn | n/a | n/a |
BGBIOBergenbio ASA | NOK34.95bn | n/a | n/a |
MORMorphosys AG | €2.59bn | n/a | n/a |
BIONBB Biotech AG | CH₣2.18bn | 7.07 | 5.04% |
BIOA BBioArctic AB | SEK21.43bn | n/a | n/a |
GLPGGalapagos NV | €1.70bn | 202.45 | n/a |
EVTEvotec SE | €1.53bn | n/a | n/a |
GNSGenus | £1.19bn | 30.46 | 1.78% |
ALIF BAddLife AB | SEK13.94bn | 378.88 | 0.44% |
PHILPhilogen SpA | €854.14m | n/a | n/a |
ABVXAbivax SA | €791.50m | n/a | n/a |
ERGOErgomed | £701.05m | 43.1 | n/a |
FYBFormycon AG | €782.20m | 6.7 | n/a |
PRTCPuretech Health | £632.77m | n/a | n/a |
GUBRAGubra A/S | DKK5.34bn | n/a | n/a |
VLAValneva SE | €572.47m | n/a | n/a |